Cerebrospinal fluid light and heavy neurofilaments in neuromyelitis optica

被引:16
|
作者
Wang, Honghao [1 ,2 ]
Wang, Conghui [3 ]
Qiu, Wei [2 ]
Lu, Zhengqi [2 ]
Hu, Xueqiang [2 ]
Wang, Kai [2 ]
机构
[1] Anhui Med Univ, Affiliated Hosp 1, Dept Neurol, Hefei, Anhui, Peoples R China
[2] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Neurol, Multiple Sclerosis Ctr, Guangzhou 510275, Guangdong, Peoples R China
[3] Anhui Med Univ, Affiliated Hosp 1, Dept Geriatr, Hefei, Anhui, Peoples R China
关键词
Neurofilament light subunit; Neurofilament heavy subunit; Neuromyelitis optica; Multiple sclerosis; FIBRILLARY ACIDIC PROTEIN; MULTIPLE-SCLEROSIS; DIAGNOSTIC-CRITERIA; CSF NEUROFILAMENT; AXONAL INJURY; BIOMARKERS; MARKER; PHOSPHORYLATION; DAMAGE;
D O I
10.1016/j.neuint.2013.10.008
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Axonal injury is the correlate of disease progression in NMO and MS. Neurofilament (NI) belongs to neuron specific intermediate filaments located in axons. Nf protein subunits are potential biomarkers in cerebrospinal fluid (CSF) for acute axonal injury. However, whether CSF NfH and Nil levels are elevated in NMO patients has remained unclear. Methods: Nf light subunit (NE) and Nf heavy subunit NfH in cerebrospinal fluid were measured by enzyme-linked immunosorbent assay (ELISA) in NMO (n = 32), MS (n = 25), and other non-inflammatory neurological disease patients (OND, n = 18). Results: CSF pNf-H levels were increased in the NMO patients compared with OND patients (p = 0.001). CSF NfL levels in the NMO patients were also higher compared with MS patients (p 0.001), and OND patients (p = 0.000001). When comparing NfL levels between MS and OND patients, there also significant differences (p = 0.0003). NMO and MS patients revealed a trend to an increased disability with increased CSF NfL during relapse (NMO: p = 0.006; MS: p = 0.017). There is positive relationship between CSF pNf-H and disability of MS patients (p = 0.041). Conclusions: CSF levels of NfL are increased in NMO patients and reflect the disease severity in NMO. (C) 2013 Published by Elsevier Ltd.
引用
收藏
页码:805 / 808
页数:4
相关论文
共 50 条
  • [41] The history of neuromyelitis optica
    Jarius, Sven
    Wildemann, Brigitte
    JOURNAL OF NEUROINFLAMMATION, 2013, 10
  • [42] The history of neuromyelitis optica
    Sven Jarius
    Brigitte Wildemann
    Journal of Neuroinflammation, 10
  • [43] Elevated cerebrospinal fluid uric acid during relapse of neuromyelitis optica spectrum disorders
    Shu, Yaqing
    Li, Haiyan
    Zhang, Lei
    Wang, Yuge
    Long, Youming
    Li, Rui
    Qiu, Wei
    Lu, Zhengqi
    Hu, Xueqiang
    Peng, Fuhua
    BRAIN AND BEHAVIOR, 2017, 7 (01):
  • [44] Cerebrospinal Fluid Levels of Soluble Amyloid Precursor Protein and β-Amyloid 42 in Patients with Multiple Sclerosis, Neuromyelitis Optica and Clinically Isolated Syndrome
    Mai, W.
    Hu, X.
    Lu, Z.
    Peng, F.
    Wang, Y.
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2011, 39 (06) : 2402 - 2413
  • [45] Cerebrospinal Fluid Level of Soluble CD27 Is Associated with Disease Severity in Neuromyelitis Optica Spectrum Disorder
    Liu, Baozhu
    Zhong, Xiaonan
    Lu, Zhengqi
    Qiu, Wei
    Hu, Xueqiang
    Wang, Honghao
    NEUROIMMUNOMODULATION, 2018, 25 (04) : 185 - 192
  • [46] Urinary trypsin inhibitor levels are reduced in cerebrospinal fluid of multiple sclerosis and neuromyelitis optica patients during relapse
    Shu, Yaqing
    Li, Rui
    Yang, Yu
    Dai, Yongqiang
    Qiu, Wei
    Chen, Ying
    Zhao, Zhihua
    Lu, Zhengqi
    Hu, Xueqiang
    NEUROCHEMISTRY INTERNATIONAL, 2015, 81 : 28 - 31
  • [47] High Level of Serum and Cerebrospinal Fluid of Heparan Sulfate and Hyaluronic Acid Might Be a Biomarker of Severity of Neuromyelitis Optica
    Zhang, Qi
    Pei, Shanshan
    Zhou, Zheyi
    Wang, Zhanhang
    Peng, Yu
    Chen, Jinyu
    Wang, Honghao
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [48] Is neuromyelitis optica associated with human leukocyte antigen?
    Zephir, H.
    Fajardy, I.
    Outteryck, O.
    Blanc, F.
    Roger, N.
    Fleury, M.
    Rudolf, G.
    Marignier, R.
    Vukusic, S.
    Confavreux, C.
    Vermersch, P.
    de Seze, J.
    MULTIPLE SCLEROSIS JOURNAL, 2009, 15 (05) : 571 - 579
  • [49] Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS)
    Trebst, Corinna
    Jarius, Sven
    Berthele, Achim
    Paul, Friedemann
    Schippling, Sven
    Wildemann, Brigitte
    Borisow, Nadja
    Kleiter, Ingo
    Aktas, Orhan
    Kuempfel, Tania
    JOURNAL OF NEUROLOGY, 2014, 261 (01) : 1 - 16
  • [50] Neuromyelitis optica
    J M S Pearce
    Spinal Cord, 2005, 43 : 631 - 634